全文获取类型
收费全文 | 641篇 |
免费 | 37篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 48篇 |
妇产科学 | 20篇 |
基础医学 | 66篇 |
口腔科学 | 37篇 |
临床医学 | 93篇 |
内科学 | 163篇 |
皮肤病学 | 10篇 |
神经病学 | 20篇 |
特种医学 | 116篇 |
外科学 | 24篇 |
综合类 | 10篇 |
预防医学 | 24篇 |
眼科学 | 3篇 |
药学 | 59篇 |
1篇 | |
肿瘤学 | 28篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 6篇 |
2019年 | 4篇 |
2018年 | 10篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 15篇 |
2014年 | 19篇 |
2013年 | 25篇 |
2012年 | 9篇 |
2011年 | 14篇 |
2010年 | 19篇 |
2009年 | 22篇 |
2008年 | 8篇 |
2007年 | 41篇 |
2006年 | 18篇 |
2005年 | 10篇 |
2004年 | 3篇 |
2003年 | 5篇 |
2002年 | 11篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 11篇 |
1998年 | 44篇 |
1997年 | 53篇 |
1996年 | 55篇 |
1995年 | 44篇 |
1994年 | 30篇 |
1993年 | 30篇 |
1992年 | 2篇 |
1991年 | 11篇 |
1990年 | 7篇 |
1989年 | 14篇 |
1988年 | 25篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1978年 | 4篇 |
1977年 | 8篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1971年 | 2篇 |
1967年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有724条查询结果,搜索用时 5 毫秒
721.
高龄冠心病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较 总被引:1,自引:0,他引:1
目的比较高龄患者经皮冠状动脉介入治疗(PCI)支架术与冠状动脉旁路移植术(CABG)对住院与临床随访结果的影响。方法212例高龄(年龄〉75岁)患者,根据血运重建方式的不同将其分为PCI支架组149例和CABG组63例,记录其临床与造影特征、血运重建情况和住院临床结果等资料,并进行临床随访。主要观察终点为住院与随访主要不良心脑血管事件(MACCE)。所有资料采用SPSS13.0软件进行统计分析,以P〈0.05为差异有统计学意义。结果与CABG组相比,PCI组的院内MACCE发生率较低(2.0%vs12.7%,χ2=10.3,P〈0.05);院内死亡率较低(2.O%V87.9%,χ^2=4.3,P〈0.05)。多因素Logistic回归分析显示,CABG组院内MACCE发生的风险显著高于PCI组(P〈0.05)。平均随访19个月(中位时间579d)显示,2组MACCE(17.2%VS13.7%,P=0.57)、再次血运重建(P〉0.05)、卒中发生率均无统计学意义(P〉0.05)。多因素Cox回归分析表明,与CABG组相比,PCI组随访期间MACCE风险较低(P〈0.05)。结论与CABG相比,高龄冠心病患者PCI术后的院内及随访主要不良心脑血管事件发生率较低。 相似文献
722.
J Weisser-Thomas VA Ferrari A Lakghomi LM Lickfett G Nickenig HH Schild D Thomas 《The British journal of radiology》2014,87(1038)
Objective
Cardiac MR (CMR) identifies the substrate of ventricular arrhythmia (VA) in cardiomyopathies and coronary heart disease. However, little is known about the value of CMR in patients with VA without previously known cardiac disorders.Methods
76 patients with VA (Lown ≥2) without known cardiac disease after regular diagnostic work-up were studied with CMR, and findings were correlated with electrocardiogram (ECG) and electrophysiological stimulation (EPS). Structural abnormalities matching the VA origin as defined by ECG and/or EPS, or a CMR-detected cardiac condition known to cause arrhythmia were defined as VA substrate. CMR findings were defined as clinically relevant, if resulting in a new diagnosis, change of treatment or additional diagnostic procedure.Results
44/76 patients demonstrated pathological CMR findings. In 24/76 patients, the pathology was detected by CMR and not by echocardiography. CMR-based diagnoses of cardiac disease were established in 20/76 patients, and all were morphological substrates for VA. In seven patients, the location of the CMR finding (scar) directly matched the VA origin. CMR findings resulted in a change of treatment in 21 patients and/or additional diagnostics in 8 patients.Conclusion
Undetected cardiac conditions are frequent causes of VA. This is the first study demonstrating the value of CMR for detection of morphological substrate and/or underlying cardiac disorders in VA patients without known cardiac disease.Advances in knowledge
The high incidence of clinically relevant CMR findings which were not detected during initial diagnostic work-up strongly supports the use of CMR to screen VA patients for underlying heart disease.Although the value of cardiac MR (CMR) for the diagnosis of cardiac diseases such as myocarditis is undisputed, CMR is also predictive of patients at high risk for ventricular arrhythmias (VAs) with conditions such as hypertrophic cardiomyopathy (HCM) and coronary heart disease (CHD).1–3 Recent studies have demonstrated the ability of CMR to identify the anatomical correlate of VA in those patients. This anatomical correlate has been characterized by CMR as a structural abnormality (e.g. fibrosis or peri-infarct region), which may go undetected using other non-invasive imaging modalities.4,5 A number of studies have been undertaken, or are ongoing, to further elucidate the added value of CMR in patients with known cardiac conditions, to improve risk stratification for VA and to optimize therapy.1,6–8 However, little is known to date regarding the added value of CMR for detection of an arrhythmogenic substrate or underlying cardiac condition in patients who present with VAs without known cardiac disease.Thus, the purpose of this study was to investigate the added value of CMR in patients with VAs for detection of underlying heart disease and an arrhythmogenic morphological substrate, and also to investigate the clinical relevance of CMR in those patients with positive findings. 相似文献723.
724.